B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

HK2

MOLECULAR TARGET

hexokinase 2

UniProt: P52789NCBI Gene: 30991 compounds

HK2 (hexokinase 2) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting HK2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1lonidamine1.102

About HK2 as a Drug Target

HK2 (hexokinase 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented HK2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

HK2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.